Cargando…

Fanconi Syndrome Induced by Tenofovir in a Diabetic Patient with a History of Chronic Hepatitis B: A Case Report

Tenofovir disoproxil fumarate is a nucleotide reverse transcriptase inhibitor and has been extensively used in the first-line treatment of viral infectious diseases such as chronic hepatitis B. Despite its good safety, the development of Fanconi syndrome is a rare adverse effect of long-term tenofov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saremi, Zeinab, Fakharian, Tahereh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Association of Gastroerterology and Hepatology 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489451/ https://www.ncbi.nlm.nih.gov/pubmed/36606019 http://dx.doi.org/10.34172/mejdd.2021.250

Ejemplares similares

Acquired Fanconi Syndrome from Tenofovir Treatment in a Patient with Hepatitis B
por: Jiang, Shirley X., et al.
Publicado: (2023)

Pathologic femoral fracture due to tenofovir-induced Fanconi syndrome in patient with chronic hepatitis B: A case report
por: Suh, You-Sung, et al.
Publicado: (2017)

Tenofovir as a Cause of Acquired Fanconi's Syndrome
por: Simon, Monisha, et al.
Publicado: (2023)

Hypokalemic paralysis secondary to tenofovir induced fanconi syndrome
por: Ramteke, Vishal V., et al.
Publicado: (2015)

Tenofovir induced Fanconi syndrome: A possible pharmacokinetic interaction
por: Kapadia, Jigar, et al.
Publicado: (2013)

Tenofovir induced Fanconi syndrome: A rare cause of hypokalemic paralysis
por: Venkatesan, E. P., et al.
Publicado: (2014)

Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature
por: Pascale, Renato, et al.
Publicado: (2017)

Impact of Tenofovir Disoproxil‐Induced Fanconi Syndrome on Bone Material Quality: A Case Report
por: Hadzimuratovic, Benjamin, et al.
Publicado: (2021)

Tenofovir Induced Fanconi Syndrome Complicated by Bilateral Neck of Femur Fractures
por: Francis, Anju K., et al.
Publicado: (2021)

Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use
por: Rao, Mana, et al.
Publicado: (2021)

Clinical Images: Tenofovir‐Induced Fanconi Syndrome: An Uncommon Cause of Hypophosphatemic Osteomalacia
por: Sahoo, Rasmi Ranjan, et al.
Publicado: (2022)

Fanconi syndrome induced by the long-term use of tenofovir disoproxil fumarate: a case report and literature review
por: Li, Jiayi, et al.
Publicado: (2023)

Intracellular tenofovir-diphosphate accumulation in an HIV-infected patient with Fanconi syndrome and osteomalacia
por: Haverkort, ME, et al.
Publicado: (2010)

Tenofovir-Induced Fanconi Syndrome Presenting with Life-Threatening Hypokalemia: Review of the Literature and Recommendations for Early Detection
por: Liatsou, Efstathia, et al.
Publicado: (2023)

Fanconi’s Syndrome and Dementia in a Patient With Chronic Hepatitis B Taking Nucleoside/ Nucleotide Analogue
por: Ho, Cheuk Wah, et al.
Publicado: (2021)

Nephrolithiasis and Osteomalacia associated with adefovir-induced Fanconi syndrome in a patient with hepatitis B
por: Lin, Jueying, et al.
Publicado: (2017)

96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients
por: Liu, Zhihong, et al.
Publicado: (2023)

Ifosfamide-induced Fanconi syndrome with diabetes insipidus
por: Leem, Ah Young, et al.
Publicado: (2014)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
por: Park, Chan Ho, et al.
Publicado: (2016)

Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2023)

New approaches in the management of chronic hepatitis B: role of tenofovir
por: Reijnders, Jurriën GP, et al.
Publicado: (2009)

Effect of tenofovir on renal function in patients with chronic hepatitis B
por: Jung, Woo Jin, et al.
Publicado: (2018)

A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation
por: Hung, Chao-Hung, et al.
Publicado: (2017)

Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
por: Yim, Hyung Joon, et al.
Publicado: (2022)

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
por: Cho, Hyeki, et al.
Publicado: (2016)

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017)

Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B
por: Sano, Tomoya, et al.
Publicado: (2021)

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
por: Lin, Hung-Yao, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Tenofovir in the Treatment of Patients with Chronic Hepatitis B
por: He, Feng, et al.
Publicado: (2022)

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
por: Kim, David Sooik, et al.
Publicado: (2019)

Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B
por: Ying, Yue, et al.
Publicado: (2018)

Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
por: Su, Pei-Yuan, et al.
Publicado: (2021)

Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B: A Systematic Review
por: Zhao, Shu-Shan, et al.
Publicado: (2011)

Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B
por: Aomura, Daiki, et al.
Publicado: (2020)

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study
por: Rodríguez, Manuel, et al.
Publicado: (2017)

Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B
por: Lee, Yoon-Suk, et al.
Publicado: (2016)

Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B
por: Cui, Guangying, et al.
Publicado: (2015)

Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B
por: Liu, Zhihong, et al.
Publicado: (2021)

Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
por: Kim, Ji Hoon, et al.
Publicado: (2015)

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
por: Lovett, Grace C, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eucjjdpcp6vakli0l44v8vfgor